Track the HLS share price and the full management transaction log of the company, a listed issuer based in Australia. Shares are listed on the AU market, under the supervision of ASX. Operating in the Health Care sector, HLS has logged 9 public disclosures. Market capitalisation: €64.3m. The latest transaction was filed on 27 August 2026 (Purchase). Among the most active insiders: its controlled bodies corporate listed in Annexure A. All data is free.
9
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 16,172 of 29,042 companies
48.9
score / 100
Value
60
Quality
38
FCF yld23%
Earn yld-18%
EV/EBITDA7.3x
ROE-14%
Gross mgn82%
Net mgn-22%
Debt/EBITDA3.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
HLS is a company operating in the healthcare and pharmaceutical sector, listed on the XASX market. It focuses on the development and commercialization of innovative solutions for the medical field.